Education
About Us
Working with TipRanks
Follow Us
iSpecimen (ISPC)
NASDAQ:ISPC
ISPC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.24 - $11.80
Previous CloseN/A
Volume25.67K
Average Volume (3M)938.80K
Market Cap
$1.30M
Enterprise Value$2.67M
Total Cash (Recent Filing)$53.89K
Total Debt (Recent Filing)$10.59M
Price to Earnings (P/E)―
Beta-0.40
Next Earnings
May 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-18.93
Shares Outstanding962,637
10 Day Avg. Volume59,229
30 Day Avg. Volume938,802
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.13
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market Cap2.05
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.52
Enterprise Value/Ebitda-0.37
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
iSpecimen News
PremiumCompany Announcements
iSpecimen Announces Key Leadership Appointments
PremiumCompany Announcements
iSpecimen Strengthens Leadership and Expands Cancer Research Focus
PremiumCompany Announcements
iSpecimen Appoints Robert Lim as New CEO
PremiumCompany Announcements
iSpecimen Inc. Reports Earnings Amid Financial Challenges
PremiumCompany Announcements
iSpecimen Announces Public Offering to Support Growth---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ISPC FAQ
What was iSpecimen’s price range in the past 12 months?
iSpecimen lowest stock price was $1.24 and its highest was $11.80 in the past 12 months.
What is iSpecimen’s market cap?
iSpecimen’s market cap is $1.30M.
When is iSpecimen’s upcoming earnings report date?
iSpecimen’s upcoming earnings report date is May 13, 2025 which is in 49 days.
How were iSpecimen’s earnings last quarter?
Currently, no data Available
Is iSpecimen overvalued?
According to Wall Street analysts iSpecimen’s price is currently Overvalued.
Does iSpecimen pay dividends?
iSpecimen does not currently pay dividends.
What is iSpecimen’s EPS estimate?
iSpecimen’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does iSpecimen have?
iSpecimen has 962,637 shares outstanding.
What happened to iSpecimen’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of iSpecimen?
Currently, no hedge funds are holding shares in ISPC
---
Company Description
iSpecimen
iSpecimen (ISPC) operates as a leading online marketplace that connects researchers with human biospecimens from a diverse network of healthcare providers. By leveraging its proprietary technology platform, the company simplifies the process of finding and obtaining samples required for medical research, diagnostics, and therapeutic development. Its platform facilitates the acquisition of a wide range of specimens, including tissues, biofluids, and more, catering to the needs of biopharmaceutical companies, academic institutions, and other research entities.
---
ISPC Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Qualigen Therapeutics
―
Verrica Pharmaceuticals
―
Replimune Group
―
Zivo Bioscience
―
Schrodinger
―
Best Analysts Covering ISPC
1 Year
1 Year Success Rate
0/13 ratings generated profit
1 Year Average Return
-66.37%
reiterated a buy rating 8 months ago
Copying Matt Hewitt's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -66.37% per trade.
---